Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth-Reference-Cited by-同舟云学术

Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth

Published:2014-06-14 Issue:2 Volume:146 Page:273-285
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Catalano Stefania,Giordano Cinzia,Panza Salvatore,Chemi Francesca,Bonofiglio Daniela,Lanzino Marilena,Rizza Pietro,Romeo Francesco,Fuqua Suzanne A. W.,Maggiolini Marcello,Andò Sebastiano,Barone Ines

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-014-3017-4.pdf

Reference66 articles.

1. Harada N (1997) Aberrant expression of aromatase in breast cancer tissues. J Steroid Biochem Mol Biol 61:175–184

2. James VH, McNeill JM, Lai LC et al (1987) Aromatase activity in normal breast and breast tumor tissues: in vivo and in vitro studies. Steroids 50:269–279

3. Esteban JM, Warsi Z, Haniu M et al (1992) Detection of intratumoral aromatase in breast carcinomas. An immunohistochemical study with clinicopathologic correlation. Am J Pathol 140:337–343

4. Chen S, Masri S, Wang X et al (2006) What do we know about the mechanisms of aromatase inhibitor resistance? J Steroid Biochem Mol Biol 102:232–240

5. Simpson ER, Michael MD, Agarwal VR et al (1997) Cytochromes P450 11: expression of the CYP19 (aromatase) gene: an unusual case of alternative promoter usage. FASEB J 11:29–36

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estrogen Regulated Genes Compel Apoptosis in Breast Cancer Cells, Whilst Stimulate Antitumor Activity in Peritumoral Immune Cells in a Janus-Faced Manner;Current Oncology;2024-08-24

2. The G Protein Estrogen Receptor (GPER) is involved in the resistance to the CDK4/6 inhibitor palbociclib in breast cancer;Journal of Experimental & Clinical Cancer Research;2024-06-18

3. Current progress and prospects for G protein-coupled estrogen receptor in triple-negative breast cancer;Frontiers in Cell and Developmental Biology;2024-02-27

4. The G Protein-Coupled Estrogen Receptor (GPER): A Critical Therapeutic Target for Cancer;Cells;2023-10-16

5. GPER deletion triggers inhibitory effects in triple negative breast cancer (TNBC) cells through the JNK/c-Jun/p53/Noxa transduction pathway;Cell Death Discovery;2023-09-26